MiMedx Group, Inc - stock earnings
MDXG Upcoming estimated earnings
Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
---|---|---|---|---|
April 30, 2024 AfterMarket | 0.07 / 0.05 | - | 84.7 million / 80.9 million | - |
MDXG Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2024Q1 | 9.1 million USD | 84.7 million USD |
2023Q4 | 62.7 million USD | 86.8 million USD |
2023Q3 | 6.8 million USD | 81.7 million USD |
2023Q2 | 1.2 million USD | 81.3 million USD |
2023Q1 | -5.0 million USD | 71.7 million USD |
2022Q4 | -415000 USD | 74.4 million USD |
2022Q3 | -8.4 million USD | 67.7 million USD |
2022Q2 | -10.9 million USD | 66.9 million USD |
2022Q1 | -10.5 million USD | 58.9 million USD |
2021Q4 | 2.2 million USD | 67.4 million USD |
2021Q3 | -2.3 million USD | 63.1 million USD |
2021Q2 | -1.8 million USD | 68.2 million USD |
2021Q1 | -8.4 million USD | 60.0 million USD |
2020Q4 | -16.6 million USD | 68.5 million USD |
2020Q3 | -19.4 million USD | 64.3 million USD |
2020Q2 | -13.3 million USD | 66.6 million USD |
2020Q1 | -6.7 million USD | 125.5 million USD |
2019Q4 | -36.2 million USD | 92.6 million USD |
2019Q3 | 12.4 million USD | 88.9 million USD |
2019Q2 | -17.2 million USD | 67.4 million USD |
2019Q1 | -13.3 million USD | 66.6 million USD |
2018Q4 | -6.7 million USD | 125.5 million USD |
2018Q3 | -178000 USD | 87.0 million USD |
2018Q2 | 1.8 million USD | 95.4 million USD |
2018Q1 | 4.6 million USD | 84.1 million USD |
2017Q4 | 34.9 million USD | 87.5 million USD |
2017Q3 | 17.5 million USD | 84.6 million USD |
2017Q2 | 8.1 million USD | 76.4 million USD |
2017Q1 | 4.3 million USD | 72.6 million USD |
2016Q4 | 5.5 million USD | 69.9 million USD |
2016Q3 | 3.3 million USD | 64.4 million USD |
2016Q2 | 2.0 million USD | 57.3 million USD |
2016Q1 | 1.2 million USD | 53.4 million USD |
2015Q4 | 13.4 million USD | 51.8 million USD |
2015Q3 | 6.6 million USD | 49.0 million USD |
2015Q2 | 5.4 million USD | 45.7 million USD |
2015Q1 | 4.1 million USD | 40.8 million USD |
2014Q4 | 3.8 million USD | 39.6 million USD |
2014Q3 | 3.7 million USD | 33.5 million USD |
2014Q2 | -390159 USD | 25.6 million USD |
2014Q1 | -922072 USD | 19.6 million USD |
2013Q4 | -1.4 million USD | 18.0 million USD |
2013Q3 | -307118 USD | 16.1 million USD |
2013Q2 | -757389 USD | 13.5 million USD |
2013Q1 | -1.6 million USD | 11.6 million USD |
2012Q4 | -1.6 million USD | 10.5 million USD |
2012Q3 | -4.2 million USD | 8.0 million USD |
2012Q2 | -744069 USD | 4.9 million USD |
2012Q1 | -1.1 million USD | 3.7 million USD |
2011Q4 | -2.6 million USD | 2.6 million USD |
2011Q3 | -1.8 million USD | 2.2 million USD |
2011Q2 | -2.5 million USD | 1.9 million USD |
2011Q1 | -3.3 million USD | 1.0 million USD |
2010Q4 | -2.7 million USD | 243918 USD |
2010Q3 | -2.9 million USD | 108027 USD |
2010Q2 | -2.7 million USD | 322075 USD |
2010Q1 | -3.1 million USD | 114855 USD |
2009Q4 | -2.2 million USD | ? USD |
2009Q3 | -4.5 million USD | ? USD |
2009Q2 | -1.6 million USD | ? USD |
2009Q1 | -2.9 million USD | ? USD |
2008Q4 | -2.3 million USD | ? USD |
2008Q3 | -3.6 million USD | ? USD |
2008Q2 | -3.2 million USD | 158260 USD |
2008Q1 | -17.4 billion USD | ? USD |
2007Q4 | -8082 USD | ? USD |
2007Q3 | -5646 USD | ? USD |
2007Q2 | -8975 USD | ? USD |
2007Q1 | -16159 USD | ? USD |
MDXG Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 67.4 million USD | 321.5 million USD |
2022 | -30.2 million USD | 267.8 million USD |
2021 | -10.3 million USD | 258.6 million USD |
2020 | -49.3 million USD | 248.2 million USD |
2019 | -30.0 million USD | 359.1 million USD |
2018 | -30.0 million USD | 359.1 million USD |
2017 | 64.7 million USD | 321.1 million USD |
2016 | 12.0 million USD | 245.0 million USD |
2015 | 29.4 million USD | 187.3 million USD |
2014 | 6.2 million USD | 118.2 million USD |
2013 | -4.1 million USD | 59.2 million USD |
2012 | -7.7 million USD | 27.1 million USD |
2011 | -10.2 million USD | 7.8 million USD |
2010 | -11.4 million USD | 788874 USD |
2009 | -8.3 million USD | ? USD |
2008 | -11.9 million USD | ? USD |
2007 | -38860 USD | ? USD |
2006 | -16738 USD | ? USD |
MDXG
Price: $7.13
52 week price:
Earnings Per Share: 0.43 USD
P/E Ratio: -389
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 527584
Ebitda: 10.3 millionMarket Capitalization: 1.1 billion